Market Scenario of the Aerospace Nanotechnology Market:

The most recent Aerospace Nanotechnology Market Research study includes some significant activities of the current market size for the worldwide Aerospace Nanotechnology market. It presents a point by point analysis dependent on the exhaustive research of the market elements like market size, development situation, potential opportunities, and operation landscape and trend analysis. This report centers around the Aerospace Nanotechnology-business status, presents volume and worth, key market, product type, consumers, regions, and key players.

Sample Copy of This Report @ https://www.quincemarketinsights.com/request-sample-62977?utm_source=TDC/komal

The prominent players covered in this report: Airbus, Glonatech, Flight Shield, Lockheed Martin, Lufthansa Technik, tripleO Performance Solution, Zyvex Technologies, CHOOSE NanoTech, General Nano, HR TOUGHGUARD, Metamaterial Technologies.

The market is segmented into By Product Type (Nanomaterials, Nanotools, Nanodevices), By End User (Aircraft Parts, Fuselage Structure, Aero Engine Parts, Aircraft Electronic Communication System, Other).

Geographical segments are North America, Europe, Asia Pacific, Middle East & Africa, and South America.

A 360 degree outline of the competitive scenario of the Global Aerospace Nanotechnology Market is presented by Quince Market Insights. It has a massive data allied to the recent product and technological developments in the markets.

It has a wide-ranging analysis of the impact of these advancements on the markets future growth, wide-ranging analysis of these extensions on the markets future growth. The research report studies the market in a detailed manner by explaining the key facets of the market that are foreseeable to have a countable stimulus on its developing extrapolations over the forecast period.

Get ToC for the overview of the premium report @ https://www.quincemarketinsights.com/request-toc-62977?utm_source=TDC/komal

This is anticipated to drive the Global Aerospace Nanotechnology Market over the forecast period. This research report covers the market landscape and its progress prospects in the near future. After studying key companies, the report focuses on the new entrants contributing to the growth of the market. Most companies in the Global Aerospace Nanotechnology Market are currently adopting new technological trends in the market.

Finally, the researchers throw light on different ways to discover the strengths, weaknesses, opportunities, and threats affecting the growth of the Global Aerospace Nanotechnology Market. The feasibility of the new report is also measured in this research report.

Reasons for buying this report:

Make an Enquiry for purchasing this Report @ https://www.quincemarketinsights.com/enquiry-before-buying/enquiry-before-buying-62977?utm_source=TDC/komal

About Us:

QMI has the most comprehensive collection of market research products and services available on the web. We deliver reports from virtually all major publications and refresh our list regularly to provide you with immediate online access to the worlds most extensive and up-to-date archive of professional insights into global markets, companies, goods, and patterns.

Contact Us:

Quince Market Insights

Ajay D. (Knowledge Partner)

Office No- A109

Pune, Maharashtra 411028

Phone: APAC +91 706 672 4848 / US +1 208 405 2835 / UK +44 1444 39 0986

Email: [emailprotected]

Web: https://www.quincemarketinsights.com

Continue reading here:
Aerospace Nanotechnology Market Trends, Industry Size, Growth, Analysis and Forecast 2028 - The Daily Chronicle

Executive summary:

The latest report on Nanotechnology in Medical Equipment market strives to provide a conclusive overview of the current and future market scenario with respect to the key growth catalysts, challenges, and opportunities across the various geographies.

The Nanotechnology in Medical Equipment market is projected to expand with a CAGR of XX% during the forecast period 2020-2025.

Request Sample Copy of this Report @ https://www.express-journal.com/request-sample/206056

In addition to region wise-assessment, the study also draws attention towards the competitive landscape by profiling the top contenders in the industry. A complete analysis of the various market segmentation is underlined in the report. Additionally, a detailed visualization of the global Covid-19 impact on the growth matrix of this business space is provided.

Market synopsis:

Regional outlook:

Product terrain outline:

Application spectrum overview:

Competitive landscape review:

Additional information from the Nanotechnology in Medical Equipment market report:

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

Market segmentation

The Nanotechnology in Medical Equipment market is split by Type and by Application. For the period 2020-2025, the growth among segments provides accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Research Objective:

Why to Select This Report:

The research process begins with internal and external sources to obtain qualitative and quantitative information related to the Nanotechnology in Medical Equipment market. It also provides an overview and forecast for the Nanotechnology in Medical Equipment market based on all the segmentation provided for the global region. The predictions highlighted in the Nanotechnology in Medical Equipment market share report have been derived using verified research procedures and assumptions. By doing so, the research report serves as a repository of analysis and information for every component of the Nanotechnology in Medical Equipment market.

Request Customization on This Report @ https://www.express-journal.com/request-for-customization/206056

View post:
Nanotechnology in Medical Equipment Market Size | Global Industry Analysis, Segments, Top Key Players, Drivers and Trends to 2025 - Express Journal

DUBLIN, Sept. 16, 2020 /PRNewswire/ -- The "Growth Opportunities for Emerging Insulation Materials" report has been added to ResearchAndMarkets.com's offering.

Material Advances Enable Development of Cost Efficient, Lightweight, and High-Performance Insulation Systems

Growth Opportunities for Emerging Insulation Materials provides a review of both current and emerging innovations on insulation materials and their potential adoption as cost-efficient and high-performance materials within industries. The research service highlights the key factors that influence R&D and adoption efforts across various geographic regions. It also provides a list of noteworthy innovations and perspectives across the globe and highlights key innovators.

Insulation materials, either in fibrous, cellular or granular form, are adopted across industries such as building and construction, packaging, electronics, consumer goods, energy, manufacturing, oil & gas, aerospace, and automotive. Apart from being a thermal barrier, the materials function as anticorrosion, anti-flame, enhance the durability, and anti-microbial protection. The insulation system comes in the form of solids, liquids or gases, helping to enhance the quality as well as reduce the tendency of energy or heat loss of the insulated product.

However, most of the traditional insulation materials, such as fiberglass, mineral wools, polyurethane foam and aluminum foil have limitations either in the form of its mechanical properties whereby it tends to break or crack when being exposed to extreme surroundings or in its thermal or chemical properties where constant exposure to extreme surroundings reduces its effectiveness. These insulation materials have also contributed to health and environment issues, such inhalation during the application of fiberglass lead could lead to lung diseases as well as the release of chlorine atoms from the polyurethane foam which leads to the thinning of the ozone layer and global warming.

Stakeholders such as the University of California, US Uppsala University, Sweden, Japan Insulation, Japan, and Showa Denko Packaging Co. Ltd., Japan have introduced approaches to develop sustainable alternatives in insulation materials. Across industries, stakeholders, such as Knauf Insulation, US, IMT Mines Als, France, Showa Denko Packaging Co. Ltd., Japan, Terreal Malaysia Sdn Bhd, Malaysia have introduced technologies such as aerogel composites, bio-based composites, aluminum-polyester composites, and ceramic nanofiber and nanocellulose as sustainable alternatives for developing cost-efficient and high-performance insulation technology.

Key Topics Covered:

1.0 Executive Summary1.1 Research Scope1.2 Research Methodology1.3 High Interest on Enhancing the Performance of Insulation Materials throughout the Regions1.4 The Multi-functional Insulation Material Exists in three Different Structures1.5 The Limitations and Opportunities of the Insulation Materials1.6 Factors influencing the Continuous Growth of Insulation Materials1.7 High Performance and Environmental Friendly Features Act as Key Factors for Material Adoption

2.0 Technology Overview2.1 Insulation Material: Definitions2.2 Fibrous Insulation is the most Mature Insulation Technology2.3 Cellular Insulation Exists in both Solid and Liquid Insulation Structures2.4 Granular Insulation has Opportunities for Developing Environmentally Friendly Insulation2.5 Enabling High-performance Reflective Insulation through Composite Technology Development2.6 Gas Insulation Has been Adopted for Enhancing other Types of Insulation Systems

3.0 Industry Assessment3.1 Overview of Insulation Material Technology3.2 Adoption of Aerogel Composite as Environmental Friendly Alternative of Insulation Technology in the Building and Construction Industry3.3 Continuous Interest Within the European Regions on Aerogel and Nanotechnology as Emerging Insulation Technology in Built Environment3.4 Certification for Insulation System Building and Construction Industries Across the North America and Europe Regions3.5 Emerging Participants in Insulating Material in the Building and Construction Industry3.6 Developing High Performance Insulation System from Recyclable Material3.7 Increasing Interest in Developing High Performance Insulation System in the Automotive, Transportation, and Aerospace Industries3.8 Emerging Participants in Insulating Material in the Automotive & Transportation, Aerospace & Defense Industries3.9 Future Potential of Sustainable Alternative of Thermal Insulation3.10 Enhancing the Performance of Insulation Technology in Electronics, Energy & Power System Industries Through Bio-based Composite3.11 Emerging Participants in Innovations in Insulating Material the in Electronic, Energy & Power System Industries3.12 The Future Potential of Lightweight, High Performance Insulation System3.13 High Research Interest of Biocomposite in Insulation System for the Packaging Industry in the European Region3.14 Emerging Participants in Insulating Material in Packaging3.15 Future Adoption of Fibrous Insulation in the Packaging Industry3.16 Gradual Interest in Adoption of Composite and Nanotechnology Alternative Within European Regions in the Manufacturing, Oil and Gas Industries3.17 Emerging Participants in the Manufacturing, Oil and Gas Industries3.18 The Adoption of Lightweight and Energy Saving Insulation System in the Manufacturing Industry

4.0 Innovations Indicators4.1 Patent Activity on Insulation Materials During 2017 to 20194.2 High Interest on Research Studies in China4.3 High Government Funding Across the Regions4.4 High Interest in Product Development Across the Regions4.5 High Interest in Technology Development in the Asia-Pacific Region4.6 Continuous Efforts in Driving Circular Approach in Industries

5.0 Future Prospects for Emerging Insulation5.1 Comparative Analysis of Emerging Insulation Materials in the Next Five Years5.2 Comparative Analysis of Potential Insulation Materials in the Next Ten Years5.3 Emerging Insulation Materials Production- Technology Comparative Analysis

6.0 Growth Opportunities for Insulation Materials6.1 Future Potential in Developing Circular Economy Within the High Performance Insulation Materials6.2 Strategic Imperatives: Critical Success Factors6.3 Growth Opportunities: Enhancing Performance of Thermal Insulating Material Through Composite Technology and Nanotechnology6.4 Increasing Number of Aerogel Composite Innovations and Nanotechnology Across the Regions6.5 Gradual Interest for Bio-based Insulation System Across the Regions6.6 High Interest in Adoption of Recycled Materials as Emerging Insulation Technology in European and Asia-Pacific Regions

7.0 Key Contacts

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/l823wz

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager [emailprotected]

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

http://www.researchandmarkets.com

Read the original:
2020 Growth Opportunities for Emerging Insulation Materials: Emerging Participants in the Manufacturing, Oil and Gas Industries - PRNewswire

Politecnico di Milano has won a new Starting Grant issued by the European Research Council (ERC), the European Unions programme that funds scientific research. Funds have been awarded to project B3YOND (acronym for Beyond nanofabrication via nanoscale phase engineering of matter), coordinated by Edoardo Albisetti, which proposes innovations in the nanomanufacturing scene.

The term designates the overall processes and techniques, which underpin the creation of new materials and devices bymanipulating matter with very high precision standards(in the range of one billionth of a millimetre!). These techniques have been an extraordinary stimulus for the development of nanoscience and of nanotechnology over the past decades. They seem to have achieved physical limitations that can only be overcome with original and entirely innovative approaches.

The aim of Albisettis project B3YOND is to innovate the nanotechnological approach by proving the efficacy of a new processing method calledphasic nano-engineering.A heat source of nanometric dimensions is positioned and shifted with the utmost precision on the materials surface in order to induce controlled phasic changes. Phasic manipulation of the material will allow to control its physical properties (e.g., electrical resistivity and conductivity, or magnetism) with unprecedented mastery. This innovative method will be used to develop a new class of artificial nanomaterials and devices for nanoelectronics and spintronics.

The project will be conducted at the Department of Physics, in partnership with PoliFab, Politecnico di Milanos micro and nanomanufacturing centre.

Counting 386 funded projects (amounting to a total of ca. 164,295,670 euro), Politecnico di Milano ranks as the first Italian university for the number of Horizon 2020 projects it has won.

Read this article:
Politecnico di Milano: Project for innovation in Nanotechnology is the winner of ERC Starting grant - Science Business

MarketQuest.biz has recently announced a new report entitled Global Healthcare Nanotechnology Market 2020 by Company, Type and Application, Forecast to 2025 offers an overview of the market by giving market data with characteristics and market chain with analysis and developments and increase. The report delivers a comprehensive analysis of the global market which presents the critical analysis of the current state of the global Healthcare Nanotechnology industry, demand for the product, environment for investment, and existing competition. Point by point data about the market players who are holding a fundamental position in the market concerning the business, revenue, open market development, and the temporary courses of action are listed in the market. It covers segments such as competitor segment, product type segment, end use/application segment, and geography segment.

NOTE: Our analysts monitoring the situation across the globe explains that the market will generate remunerative prospects for producers post COVID-19 crisis. The report aims to provide an additional illustration of the latest scenario, economic slowdown, and COVID-19 impact on the overall industry.

Key Players Profiles:

The report provides present competitive analysis as well as valuable insights to industries or other clients to help them penetrate in a global market. Businesses will get a competitive advantage from this competitive research analysis. The report then covers gives a detailed overview of global Healthcare Nanotechnology industry prime vendors and regional evaluation with forecast period 2020 to 2025. The research focuses on primary and secondary drivers, market share, leading segments, and regional analysis. It also delivers the market competitive landscape and an elementary inspection of the regional growth of the market.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketquest.biz/sample-request/17915

Developments and future opportunities estimated to emerge in the global Healthcare Nanotechnology industry are looked into in this portion of the study. The report also throws light on the competitive landscape, underlining the corporate strategies that the prominent players across various geographies have employed to get ahead in this industry. The research focuses on business consulting, industry chain research, and consumer research to help customers provide non-linear revenue models within this market.

Geographically, this report is segmented into several key regions including North America (United States, Canada and Mexico), Europe (Germany, France, United Kingdom, Russia and Italy), Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia), South America (Brazil, Argentina), Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa). Moreover, the market potential for each geographical region with respect to the growth rate, macroeconomic parameters, consumer buying patterns, and market demand and supply scenarios is analyzed in this report.

This research report also includes profiles of major companies operating in the global market. Some of the prominent players operating in the global Healthcare Nanotechnology market are: Amgen, Merck & Co, UCB, Teva Pharmaceuticals, Sanofi, Abbott, Stryker, Celgene, Roche, Biogen, Smith & Nephew, Shire, Gilead Sciences, Endo International, Leadiant Biosciences, Johnson & Johnson, Pfizer, Ipsen, Kyowa Hakko Kirin, 3M Company

Based on type, the market has been segmented into: Nanomedicine, Nano Medical Devices, Nano Diagnosis, Others

Based on application, the market has been segmented into: Anticancer, CNS Product, Anti-infective, Others

ACCESS FULL REPORT: https://www.marketquest.biz/report/17915/global-healthcare-nanotechnology-market-2020-by-company-type-and-application-forecast-to-2025

Key Features of The Global Market Report:

Customization of the Report:

This report can be customized to meet the clients requirements. Please connect with our sales team ([emailprotected]), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

MarketQuest.biz is a leading global Market Research agency providing expert research solutions, trusted by the best. We understand the importance of knowing what global consumers watch and buy, further using the same to document our distinguished research reports. MarketQuest.biz has worldwide presence to facilitate real market intelligence using latest methodology, best-in-class research techniques and cost-effective measures for worlds leading research professionals and agencies. We study consumers in more than 100 countries to give you the most complete view of trends and habits worldwide. MarketQuest.biz is a leading provider of Full-Service Research, Global Project Management, Market Research Operations and Online Panel Services.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: [emailprotected]Web: http://www.marketquest.biz

View original post here:
Global Healthcare Nanotechnology Market With COVID-19 Pandemic Analysis, Growth Rate and Forecast 2020-2025 - The Daily Chronicle

The newly added research report entitled Global Healthcare Nanotechnology Market 2020 by Company, Regions, Type and Application, Forecast to 2026 carries-out a multi-dimensional assessment gauging into factors such as vendor landscape with references of competitors, their market positions as well as revenue generation status. The report focuses on covering several factors such as global distribution, manufacturers, market size, and market factors that affect the global contributions that are reported in the study. The report analyzes vital developments along with evaluating multiple growth challenges, and threats, as well as opportunity analysis that collectively decide growth prognosis in the global Healthcare Nanotechnology market. It shows an exhaustive summary of the vendor landscape, competitive analysis, and competitive advantage.

Market Landscape Analysis:

The report delivers a complete overview of segments and the regional outlook of the market. It shows comprehensive insights on the latest industry trends, forecast, and growth drivers in the market. The report also focuses on comprehensive market revenue streams along with growth patterns, analytics focused on market trends, and the overall volume of the market. It mainly studies the market size, recent trends, and development status of the global Healthcare Nanotechnology market as well as market dynamics including drivers, restraints, opportunities, supply chain. The report offers relevant information such as the relationship between production and consumption, supply and demand, the relationship between imports and exports, and demand trends in each region. The report also covers a country-by-country analysis of the market segments and sub-segments.

NOTE: Our report highlights the major issues and hazards that companies might come across due to the unprecedented outbreak of COVID-19.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketsandresearch.biz/sample-request/41102

Market Competition By Player:

The report shows how the competition in the global Healthcare Nanotechnology market is growing or decreasing based on deep analysis of market concentrate rate, competitive situations and trends, expansions, merger and acquisition deals, and other subjects. It also shows how different companies are progressing in the market in terms of revenue, production, sales, and market share. Every player is studied in the report on the basis of the main business, gross margin, revenue, sales, price, competitors, manufacturing base, product specification, product application, and product category.

The major players profiled in this report include: Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen, Stryker, Gilead Sciences, Pfizer, 3M Company, Johnson & Johnson, Smith & Nephew, Leadiant Biosciences, Kyowa Hakko Kirin, Shire, Ipsen, Endo International,

Based on product type, the market is segmented into: Nanomedicine, Nano Medical Devices, Nano Diagnosis, Other

Based on application, the market is segmented into: Anticancer, CNS Product, Anti-infective, Other,

Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2015-2026) of the following regions: North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

ACCESS FULL REPORT: https://www.marketsandresearch.biz/report/41102/global-healthcare-nanotechnology-market-2020-by-company-regions-type-and-application-forecast-to-2026

The report provides an overview of the global Healthcare Nanotechnology market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of the market by type, application, and region are also given in this report. It provides a competitive situation and market concentration status along with the basic information of these players.

Customization of the Report:

This report can be customized to meet the clients requirements. Please connect with our sales team ([emailprotected]), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

Marketsandresearch.biz is a leading global Market Research agency providing expert research solutions, trusted by the best. We understand the importance of knowing what global consumers watch and buy, further using the same to document our distinguished research reports. Marketsandresearch.biz has worldwide presence to facilitate real market intelligence using latest methodology, best-in-class research techniques and cost-effective measures for worlds leading research professionals and agencies. We study consumers in more than 100 countries to give you the most complete view of trends and habits worldwide. Marketsandresearch.biz is a leading provider of Full-Service Research, Global Project Management, Market Research Operations and Online Panel Services.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: [emailprotected]Web: http://www.marketsandresearch.biz

Other Related Reports:

Global Panel Furniture Equipment Market 2020 Size, Market Share, Key Players, Segmentation Development and Forecast by 2025

Global Automatic Sorting Machine Market 2020 Product Type, Applications, Market Share and Forecast by 2025

Global Hand Riveter Market 2020 Segmentation, Statistics, Top Manufacturers, Regional Analysis and Forecast to 2025

Global Electronic Yarn Market 2020 Industry Overview, Competition by Manufacturers, Production Capacity by Region, Forecast by 2025

Global Cell Phone Ceramic Part Market 2020 Key Drivers and Challenges, Opportunities and Forecast Insights by 2025

https://neighborwebsj.com/

The rest is here:
Global Healthcare Nanotechnology Market 2020 Top Manufactures, Growth Opportunities and Investment Feasibility 2026 NeighborWebSJ - NeighborWebSJ

Nov 05, 2021(Nanowerk News) An international research team, led by scientists from the EMPA (Zurich) and the International Iberian Nanotechnology Laboratory, which has researchers from the UPV/EHU, has succeeded in building chains of quantum magnets made of nanographene that capture the essence of one of the core models of quantum magnetism. The team's results (Nature, "Observation of fractional edge excitations in nanographene spin chains") have implications for understanding quantum magnetism on the nanoscale and may open the door to building quantum computers.Artistic rendering of a triangulene quantum spin chain adsorbed on a gold surface and probed with the sharp tip of a scanning tunneling microscope. While each triangulene unit (triangular nanographenes) has a total spin of 1, quantum correlations in the chain lead to spin fractionalization, such that the terminal triangulene units exhibit a spin of ½. (Image: EMPA)We are all used to the idea that simple units combine to form more complex structures. So atoms combine to form molecules, which in turn combine to form cells, and cells form tissue, ultimately giving rise to living beings.In the quantum world, this process may take place in reverse in such a way that the interaction between complex particles results in simpler particles. So, under certain circumstances, the interaction between electrons, indivisible particles with electric charge e, gives rise to the emergence of particles with charge e/3. This phenomenon is known as fractionalization.Quantum magic: fractionalizing spinsAll elementary particles have intrinsic properties such as mass or charge that are intuitive to us, and others such as spin, which can be visualised like a compass. However, unlike normal compasses, which can point in any direction, the spin of quantum systems is quantized, and can only assume a discrete set of values. For example, we say that the spin of an electron is ½ and can only take two values. Particles with spin 1 can take three values.In the 1980s the British physicist Duncan Haldane built a mathematical model for spin 1 particles in which the fractionalization of the spins took place. So when a one-dimensional chain of indivisible spin 1 particles interacted with their neighbours, they gave rise to the emergence of spin ½ particles on the edges of the chain.Like the magic trick in which the magician saws a person in half and pulls the two halves apart, the Haldane model allows spins 1 to be fractionalized and separated. It is one of the core models of quantum magnetism, and his work earned him the Nobel Prize in 2016.One-dimensional chains of magnetic molecules assembled from grapheneExperimental confirmation of this prediction was challenging for various reasons, chief among them being the fact that one-dimensional materials do not exist. Indirect evidence of the phenomenon of spin fractionalization in organometallic materials containing chains of magnetic atoms existed, but direct observation remained elusive.Now, however, that observation has been made by an international team of researchers, including the Ikerbasque researcher David Jacob of the Department of Polymers and Advanced Materials: Physics, Chemistry and Technology at the UPV/EHU; he has collaborated in this work with the INL, the University of Alicante, the EMPA in Zurich and the University of Dresden.To accomplish this difficult feat, the researchers combined organic chemistry techniques with ultra-high vacuum surface science in order to synthesise graphene molecules with spin 1 that form unidimensional chains. Using a tunnelling microscope, the team of researchers were able to study, with atomic resolution, the quantum states of the chain adsorbed on a gold surface, compare them with those predicted by the theory, and establish that the system did in fact behave like the Haldane model.In particular, in chains with a sufficiently high number of magnetic molecules, the researchers found Kondo resonances at the tips of the chain, a phenomenon that occurs when spin ½ particles interact with the electrons in a conductor such as gold.From one-dimensional chains to two-dimensional networks and quantum computersThe researchers say that this work "shows the potential for using nanographenes to form two-dimensional networks of nanomagnets, enabling predictions analogous to Haldane's to be confirmed, such as, for example, the existence of quantum states that would allow quantum computation to be carried out".

Go here to see the original:
Exotic magnetic states on the nanoscale - Nanowerk

The report provides a detailed assessment of theGlobal Nanotechnology Drug Delivery Market Research Report 2020-2025.This includes enabling technologies, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmaps, value chains, ecosystem player profiles, and strategies included. The report also presents a SWOT analysis and forecast for Nanotechnology Drug Delivery investments from 2020 to 2025. The report explores the current outlook in global and key regions (North America, Europe, Asia-Pacific, and Latin America) from the perspective of players, countries (U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc.), product types, and end industries.

Get Sample PDF Copy of Latest Research on Nanotechnology Drug Delivery Market

https://www.marketintelligencedata.com/reports/80459/nanotechnology-drug-delivery-market-growth-trends-and-forecasts-2020-2025/inquiry?Mode=19&MW

Key Market Trends:Application in Cardiovascular Segment is Expected to Cover a Large Market ShareCardiovascular Diseases (CVD) are the leading cause of death globally. According to estimates by the World Health Organization, an estimated 17.9 million people died from CVDs in 2016, representing 31% of all global deaths. Of these deaths, 85% were due to heart attack and stroke. Moreover, some other reports have also reported that the prevalence and number of deaths due to CVDs have increased and are expected to increase in future as well.

According to the American Heart Association, the deaths per year are estimated to grow to more than 23.6 million by 2030. The increasing number of deaths will lead to increased burden among the people, which will increase the demand for novel nanotechnology drug delivery techniques that are efficient than traditional medicine and hence this is expected to drive the overall market to grow.

To Understand How Covid-19 Impact Is Covered in This Report

https://www.marketintelligencedata.com/reports/80459/nanotechnology-drug-delivery-market-growth-trends-and-forecasts-2020-2025?Mode=19&MW

Influence of the Nanotechnology Drug Delivery Market report:Comprehensive assessment of all opportunities and risks in the Nanotechnology Drug Delivery Market.Nanotechnology Drug Delivery Market recent innovations and major events.A detailed study of business strategies for the growth of the Nanotechnology Drug Delivery Market market-leading players.Conclusive study about the growth plot of Nanotechnology Drug Delivery Market for forthcoming years.In-depth understanding of Nanotechnology Drug Delivery Market, market-particular drivers, constraints, and major micro markets.Favorable impression inside vital technological and market latest trends striking the Nanotechnology Drug Delivery Market.

The research includes historic data from 2015 to 2020 and forecasts until 2025 which makes the reports an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs.

About Us:Market Intelligence Data provides syndicated market research on industry verticals including Healthcare, Information, and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc.,Market Intelligence Data provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us:Irfan Tamboli (Head of Sales) | Market Intelligence DataPhone: +1 (704) 266-3234sales@marketintelligencedata.com

Read more here:
Nanotechnology Drug Delivery Market Insights, Trends and Huge Business Opportunities 2020-2025 The Courier - The Courier

ACCESSWIRE2020-10-30

LOS ANGELES, CA / ACCESSWIRE / October 30, 2020 / California Nanotechnologies Corp. (TSXV:CNO)(OTC PINK:CANOF) ("Cal Nano" or the "Company") is pleased to announce that revenue for the quarter ending August 31, 2020 was $287,768. This represents the 2nd largest quarterly revenue in the Company's history. Net income for the quarter was $20,365. The full financial statements available at sedar.com.

Division

Sales Year

Spark Plasma Sintering

Research and Development

Sport and Recreation

2020

85%

14%

1%

2019

60%

31%

9%

The Company has achieved six month revenue of $455,305 which is an increase 8.2% or $24,547 from the same period last year, of $420,758. "Our ongoing collaboration with Idaho National Lab and other industry leaders with programs involving both cryomilling and SPS contributed to record revenue for the first half of the fiscal year" stated Eric Eyerman, CEO.

Cal Nano is pleased to announce that it is continuing to add new customers to its portfolio. The number of R&D projects, for both, new and existing customers, continues to grow. Cal Nano has added over a dozen new customers for new R&D programs using our expertise in cryomilling and SPS capabilities. "These new customers are expanding our production capabilities and driving a higher revenue performance for this quarter" stated Eric Eyerman, CEO.

For further information, please contact:

Eric Eyerman, CEOT: (562)-991-5211E: info@calnanocorp.comW: http://www.calnanocorp.com

Reader Advisory

Except for statements of historical fact, this news release contains certain "forward-looking information" within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur. In particular, forward-looking information in this press release includes, but is not limited to the expected future performance of the Company. Although we believe that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. We cannot guarantee future results, performance or achievements. Consequently, there is no representation that the actual results achieved will be the same, in whole or in part, as those set out in the forward-looking information. Forward-looking information is based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking information. Some of the risks and other factors that could cause the results to differ materially from those expressed in the forward-looking information include, but are not limited to: general economic conditions in Canada, the United States and globally; industry conditions, governmental regulation, including environmental regulation; unanticipated operating events or performance; failure to obtain industry partner and other third party consents and approvals, if and when required; the availability of capital on acceptable terms; the need to obtain required approvals from regulatory authorities; stock market volatility; competition for, among other things, capital, skilled personnel and supplies; changes in tax laws; and the other risk factors disclosed under our profile on SEDAR at http://www.sedar.com. Readers are cautioned that this list of risk factors should not be construed as exhaustive.

The forward-looking information contained in this news release is expressly qualified by this cautionary statement. We undertake no duty to update any of the forward-looking information to conform such information to actual results or to changes in our expectations except as otherwise required by applicable securities legislation. Readers are cautioned not to place undue reliance on forward-looking information.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

W. http://WWW.CALNANOCORP.COME. INFO@CALNANOCORP.COMP. 562.991.5211F. 562.926.6913

SOURCE:California Nanotechnologies Corp.

View source version on accesswire.com: https://www.accesswire.com/613359/California-Nanotechnologies-Announces-Positive-Q2FY2021-Results

Visit link:
California Nanotechnologies Announces Positive Q2/FY2021 Results - IT News Online

CEMEX and Carbon Upcycling anticipate initial results from this joint research and development effort by mid-2021.

Carbon Upcycling

CEMEX has signed an agreement with Carbon Upcycling Technologies intending to improve the processing of residue or by-products of industrial processes, capturinglow carbon dioxide (CO2)emissions to produce nanomaterials with greater reactivity and a lower carbon footprint. This would allow the production of concretes with a low CO2footprint that meets the construction industry's requirements.

CEMEX signed the agreement with Carbon Upcycling, a company that develops nanomaterials derived from the use of CO2for industrial use, through its corporate venture capital unit, CEMEX Ventures.

While CEMEX uses 3 million tons of industrial residue each year, as additions to cement and concrete, a large portion of industrial waste produced annually cannot be recycled due to its low reactivity. Large quantities of residue or by-products are deposited in landfills and dumpsites, creating significant economic, environmental, and social costs.

This initiative seeks to increase industrial residue's reactivity property, allowing more availability of additions with cementitious qualities. With this venture, CEMEX expects to double its current use of industrial residue to consume annually 6 million tons by 2030, thereby reducing its carbon footprint significantly.

Carbon Upcycling technology transforms residues such as fly ash and slag, making them more reactive and increasing their cementitious properties. The use of CO2previously captured, combined with a physical transformation of the material during the process, generates a new addition for the cement that allows the production of concrete with a low environmental footprint. The improvement in the cementitious capacity of materials achieved by the Carbon Upcycling technology will expand the range of sources that can be used to reduce the amount of clinker needed in cement production and the amount of cement required in concrete.

The agreement will begin with a coordinated analysis between CEMEX and Carbon Upcycling and its implementation on an industrial scale. CEMEX and Carbon Upcycling anticipate initial results from this joint research and development effort by mid-2021.

"This agreement with Carbon Upcycling is yet another example of our determination to deliver net-zero CO2concrete products globally by 2050," says Gonzalo Galindo, head of CEMEX Ventures. "Our roadmap to achieve this global ambition involves continuing to innovate our technology internally while, at the same time, continuing to seek complementary innovation outside of CEMEX through investments in startups, consortia, and high-value collaboration agreements such as the one reached with Carbon Upcycling."

"We're thrilled to be partnering with CEMEX Ventures on this initiative and working with CEMEX to achieve their net-zero CO2commitment," says Apoorv Sinha, CEO of Carbon Upcycling Technologies. "Investigating industrial residue that could be upcycled will unlock the applicability of our technology to achieve emissions reduction in concrete products globally. This works towards a larger vision of beneficiating under-utilized materials, such as natural pozzolanic materials, to reduce the use of portland cement in commercial concrete mixes. We've already shown the ability to reduce cement use by over 10% in field deployments across Calgary and are confident that this number can be significantly improved with further research and development."

See more here:
CEMEX and Carbon Upcycling Technologies to Use Nanotechnology to Produce Low Emission Concrete - ForConstructionPros.com

The Sri Lanka Institute of Nanotechnology functioning under the purview of the State Ministry of Technology and Innovation has been successful in developing LAMP ( Loop-Mediated Isothermal Amplification) PCR test kit to be used in the detection of covid-19 virus. Compared with the test kit previously used in the RT- PCR machine, this new test kit helps in reducing the time and cost spent on a PCR test. A continuous supply can also be ensured as this test kit is produced within our country.

This LAMP PCR test kit is presently at the clinical trial phase and is due to be introduced to the countrys health sector ,shortly. During the recent past, the Sri Lanka Institute of Nano Technology commenced the manufacture of SWABS being used in the covid-19 virus detection test, within the country and supplied the product to the Health Services Supplies Division and to the Medical Research Institute. It was decided to continue with the production of SWBS.

These matters were highlighted at a discussion held at the Ministry of Health, presided by DR (Mrs) Seetha Arambepola, State Minister of Skills Development Vocational Education, Technology and Innovation, precipitated by the current situation of the country in relation to covid-19 outbreak.

This discussion was attended by Dr.(Mrs) Seetha Arambepola, State Minister of Skill Development, Vocational Education, Technology and Innovations, Dr. Sanjaya Munasinghe, Secretary to the Ministry of Health, Deepa Liyanage Additional Secretary to the State Ministry of Technology and Innovation, Mr. Manju Gunawardhana, Director - Sri Lanka Institute of Nanotechnology, Mr. Heminda Jayaweera, Chief Operations Officer - Sri Lanka Institute of Nanotechnology, Dr. Kamal Jayasinghe, Director General of the National Drug Regulatory Authority, Dr. Prabath Amarasinghe, Acting Director of the Medical Research Council.

Original post:
LAMP PCR test kit from the Institute of Nanotechnology - Sunday Observer

LA JOLLA, Calif. (PRWEB) October 09, 2020

Nanotechnology has long been understood to support many facets of medical science. Researchers and manufacturers are taking this proven technology and are now applying it to one of the fastest growing consumer markets in the world - CBD. And no one has been more active in bringing this tiny technology to CBD consumers than CBD Products Inc, with their new nano inspired brand Cannabinoid Balance.

Having seen that nanotechnology could have a profound effect on absorption rates in the body, the team at CBD Products Inc. turned to NanoZorb to help deliver the cannabinoids and terpenes in their Cannabinoid Balance products into the bloodstream quicker.

As with so many things in science, Nano Technology works by increasing the contact area and in turn increases the rate of absorption. By using NanoZorbTechnology in their Cannabinoid Balance products, Anthony Tribunella realized that he could increase the rate of CBD uptake and make the process of absorption more efficient by bypassing the digestive tract and reducing the CBD degradation that occurs during digestion.

Nano Technology describes the creation of minute particles, so small in fact that millions of them could fit on to just one pinhead. These tiny particles are small enough to be absorbed directly into the bloodstream and delivered to every cell. This means that unlike traditional delivery methods, the constituents being delivered in Cannabinoid Balance's case get to work as quickly as possible. This makes the product more efficient and therefore more cost-effective per mg.*

It sounds like something out of a Science Fiction movie, but this incredible real-life science is safe, simple, and effective. The NanoZorb technology used in Cannabinoid Balance products is developed in an FDA registered facility, so consumers can rest assured that it is safe, effective and often more efficient than products that dont utilize this incredible technology.*

*The statements and products referred to by Cannabinoid Balance have not been evaluated by the FDA.

CBD Products Inc. is a multi-channel, CBD publishing and retail company established in 2018 that owns and operates cbdproducts.com, cbdworldnews.com and cbdpet.com. In the last year CBD Products Inc. has welcomed more than 25,000 people to their sites and offered information and resources across more than 100,000 page views.

CBD Products Inc. is also the owner of Cannabinoid Balance. A line of consumer products that includes Cannabinoid Balance Original+, Cannabinoid Balance Sleep+, Cannabinoid Balance CBD Gummies+, Cannabinoid Balance Pain Relief Cream and Cannabinoid Balance Pet+. These products are sold via http://www.cbdproducts.com and include proprietary NanoZorb Technology designed to make Cannabinoid Balance products more effective and efficient.

It was founded by Anthony Tribunella in 2018. Anthony has worked in all aspects of the industry from growing to production, to publishing and retailing. With more than a decade of experience in CBD and a passion to see the industry become organized and honest, Anthony is rapidly becoming a shining light, thought leader and conscience for the industry he cares so deeply about.

For more information on CBD Products Inc. please visit http://www.cbdproducts.com or email contact@cbdproducts.com.

Share article on social media or email:

Originally posted here:
The Tiny Technology Helping Cannabinoid Balance By CBD Products Inc. Make A Big Splash - PR Web

Oct-2020 Updated Report: Final Report will add the analysis of the impact of COVID-19 on this industry.

Global Nanotechnology Market Research Report presents a competitive assessment and detailed statistical analysis on Nanotechnology Industry prospects. The Nanotechnology Report will enlighten the readers with market dynamics and market trends to provide a holistic market overview. The key aspects of Nanotechnology Industry like market growth, market dynamics, threats and cost structures are presented in the report. The emerging market trends, latest development, R&D status, and key vendors are analysed at depth. The Nanotechnology report is segmented based on product type, application and top geographical regions.

To Understand How Covid-19 Impact on this industry. Get Free Sample Report:

https://www.globalmarketers.biz/report/others/global-nanotechnology-market-report-2020-by-key-players,-types,-applications,-countries,-market-size,-forecast-to-2026-(based-on-2020-covid-19-worldwide-spread)/155227#request_sample

Major players covered in this report:

ClariantKumho Petrochemical3MThomas SwanNanophase TechnologiesOxford Nanopore TechnologiesHitachiArkemaShenzhen DynanonicApplied MaterialsShowa DenkoMinerals TechnologiesOcsialSakai ChemicalCnano TechnologyDuPontMitsubishi ChemicalBASFTorayUnitikaNanometrics IncorporatedEvonik

Global Nanotechnology Market Segmentation:

By Type:

NanomaterialsNanotoolsNanodevices

By Application:

BiomedicalElectronicsEnergyEnvironmentalManufacturingOthers

The future Nanotechnology Industry predictions explain the forecast market values, industry progress, upcoming plans and policies. Also, the volume, value and consumption forecast view is presented from 2019-2026. The strategies implemented by top Nanotechnology players, as well as historic and present market performance is portrayed in this report. The Nanotechnology fundamental market overview, market share, import-export status, and pricing structure is presented. The report begins with Nanotechnology research objectives, definition, market scope and size estimation. The growth rate from 2014-2026 and complete Nanotechnology Industry picture is covered.

Get Up to 40% Off on purchasing this report, Ask Here for Discount @:

https://www.globalmarketers.biz/discount_inquiry/discount/155227

All top product types, applications and regions namely North America, Europe, Asia-Pacific, South America, and Middle East & Africa are analysed. A complete market outlook from 2014-2026 with country-level analysis for above-mentioned regions is covered in the report. The top countries analysed in the report include United States, Canada, Mexico, France, Germany Italy, UK, Russia, China, Korea, Japan, India, Brazil, South Africa, Egypt, Turkey and Saudi Arabia are profiled in the report. Other regions/countries can be added based on user requirements.

Next segment explains the Nanotechnology market dynamics presenting the opportunities, risks and market driving forces. Also, the top manufacturers profile analysed in the study explains their business portfolio, market growth, market share for every type and application as well as their geographical presence. A complete estimation of sales margin, price, revenue share and gross margin is explained. The sales and marketing channels of Nanotechnology, traders, distributors and dealers of Nanotechnology Market are evaluated completely.

Inquire Before Buying Or Ask For More Details:

https://www.globalmarketers.biz/report/others/global-nanotechnology-market-report-2020-by-key-players,-types,-applications,-countries,-market-size,-forecast-to-2026-(based-on-2020-covid-19-worldwide-spread)/155227#inquiry_before_buying

The Primary Objectives of Nanotechnology Market Research Report Are As Follows:

The top-down and bottom-up approach is implied to study the Nanotechnology Market statistics and analytical details. The data is presented in the form of graphs, tables, and figures to provide ease of understanding. The SWOT analysis, investment return analysis and mergers & acquisitions in Nanotechnology Industry are stated. The changes in business structure, plans & policies and emerging players are analysed in detail. This report will be useful for all market participants and business consultants to understand Nanotechnology market trends, growth drivers and challenges.

View Full Table Of Content: @

https://www.globalmarketers.biz/report/others/global-nanotechnology-market-report-2020-by-key-players,-types,-applications,-countries,-market-size,-forecast-to-2026-(based-on-2020-covid-19-worldwide-spread)/155227#table_of_contents

Contact Us:

Name: Alex White

Phone: US: +1(806)4400782/ UK: +44 33 3303 4979

Email: [emailprotected]

See the original post:
Global Nanotechnology Market-Global Potential Growth, Demand by Regions, Types and Analysis of Key Players;Research Forecasts to 2026 - Eurowire

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global particle size analyzer market size and it is poised to grow by USD 94.95 million during 2020-2024, progressing at a CAGR of about 5% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavios in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. We offer $1000 worth of FREE customization

The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Agilent Technologies Inc., Anton Paar GmbH, Beckman Coulter Inc., FLSmidth & Co. A/S, HORIBA Ltd., Malvern Panalytical Ltd., Micromeritics Instrument Corp., Microtrac Retsch GmbH, Shimadzu Corp., and TSI Inc. are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Growing applications of nanotechnology have been instrumental in driving the growth of the market. However, the high overall expense might hamper the market growth.

Technavio's custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations. Download a Free Sample Report on COVID-19 Impacts

Particle Size Analyzer Market 2020-2024: Segmentation

Particle Size Analyzer Market is segmented as below:

Particle Size Analyzer Market 2020-2024: Scope

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The particle size analyzer market report covers the following areas:

This study identifies the growing applications in the pharmaceutical industry as one of the prime reasons driving the Particle Size Analyzer Market growth during the next few years.

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavios in-depth research has direct and indirect COVID-19 impacted market research reports.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

Particle Size Analyzer Market 2020-2024: Key Highlights

Table of Contents:

Executive Summary

Market Landscape

Market Sizing

Five Forces Analysis

Market Segmentation by Technology

Market Segmentation by End-user

Customer landscape

Geographic Landscape

Vendor Landscape

Vendor Analysis

Appendix

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Continue reading here:
COVID-19 Recovery Analysis: Global Particle Size Analyzer Market | Growing Applications of Nanotechnology to Boost Market Growth | Technavio -...

Written by AZoNanoOct 5 2020

The heterogeneity of cancer cells themselves is one of the main difficulties faced in the development of effective and targeted treatments for cancer. This change makes it hard for the immune system to identify, react to, and actively fight against tumors.

But new advances in the field of nanotechnology are currently rendering it feasible to provide targeted and personalized vaccines to treat cancer.

A new study, reported recently in the Science Advances journal, describes the use of charged nanoscale metal-organic frameworks and X-rays to produce free radicals inside tumor tissue to directly destroy the cancer cells.

Moreover, it is possible to use the same frameworks to provide immune signaling molecules called PAMPs to trigger the immune response against tumor cells. By integrating these two methods into one vaccine that can be easily administered, this new technology could pave the way to improve local and systemic treatment of cancers that are hard to treat.

As part of a collaboration between the Lin Group from the Department of Chemistry at the University of Chicago and the Weichselbaum Lab at the University of Chicago Medicine, the researchers combined expertise from cancer biology and inorganic chemistry to address the challenging issue of correctly targeting and triggering an innate immune response against cancer.

This study took advantage of the special properties of nanoscale metal-organic frameworks (nMOFs), which are nanoscale structures made of recurring units arranged in a lattice formation and with the ability to infiltrate tumors.

Such nMOFs can be irradiated with the help of X-rays to produce high concentrations of free oxygen radicals, thereby directly killing the cancer cells and generating inflammatory molecules and antigens helping the immune system identify and clear cancerous cells, quite similar to a vaccine.

Moreover, the lattice-like structure of the nMOFs makes them ideal transporters to directly deliver anti-cancer drugs to tumors. But to date, it has been challenging to trigger innate and adaptive immune responses essential for destroying cancerous tumors.

As part of the new research, the team further refined their technique. They produced a new kind of nMOF structure that can be loaded with drugs called pathogen-associated molecular patterns (PAMPs).

Upon applying the nMOFs to cancerous tumors, irradiation of the tissue had a double impact: it activated the nMOFs to destroy local cancer cells to create antigens against the tumor and discharged the PAMPs, which subsequently triggered a much more powerful activation of the immune response to the tumor antigens.

This one-two punch could destroy both pancreatic and colon cancer cells with high efficacy, even in tumor models that are considerably resistant to other types of immunotherapy.

The investigators performed additional experiments with mice and observed that they could expand the impacts of the nMOFs even to distant tumors by applying checkpoint inhibitors, offering new hopes for treating cancer both systemically and locally with this method.

By including PAMP delivery with the nMOFs, this is the first time we were able to really enhance the immune response to the antigens. This is entirely different from all of our previous studies because weve shown that the nMOFs plus PAMPs can impact all of the aspects required for activating the immune system.

Wenbin Lin, PhD, Study Senior Author and James Franck Professor of Chemistry, University of Chicago Medical Center

We can use this nanoformulation to enable personalized cancer vaccinations that will work on any patient because this strategy will not be subject to the heterogeneity we see among different patients, added Lin.

The impacts of the treatment were so marked that the scientists are keen to bring the technology to clinical trials, whereas the other versions of the nMOF technology are already being tested, with encouraging results until now.

The brilliance of this system is twofold. First, it can improve local tumor control by increasing the killing power of X-rays. Second, while there has been interest in using radiation to stimulate the immune response to fight cancer, it has turned out to be harder than we thought.

Ralph Weichselbaum, MD, Study Co-Author and Daniel K. Ludwig Distinguished Service Professor of Radiation and Cellular Oncology, University of Chicago Medical Center

In this case, the nMOFs are able to activate the innate and adaptive immune systems, which makes this technology very promising for treating cancer in the clinic, added Weichselbaum, who is also the Chair of the Department of Radiation and Cellular Oncology at UChicago.

The investigators are already looking forward to next steps and striving to fine-tune the technology. Were refining the design of the nMOF and its delivery of the PAMPs, in preparation for testing it in humans, stated Lin. Were really working on zooming in on the best formulation so we can get this into clinical trials, hopefully in the next two to three years, or even sooner.

The researchers acknowledge the interdisciplinary and collaborative nature of UChicago and the University of Chicago Medicines Hyde Park campus for making a space where cancer biology and chemistry have combined to create such an encouraging potential therapy, as well as the support they have received from Ludwig Cancer Research along the way.

From the conception of this project and getting it funded to starting with clinical trials where were able to test the technology in clinical trials and get real patient data, this work has all been done right here at UChicago. We really are going from discovering something in the lab to testing it at the bedside.

Ralph Weichselbaum, MD, Study Co-Author and Daniel K. Ludwig Distinguished Service Professor of Radiation and Cellular Oncology, University of Chicago Medical Center

The study titled Nanoscale metal-organic frameworks for x-ray activated in situ cancer vaccination was financially supported by the National Cancer Institute (U01-CA198989 and 1R01CA253655), the Department of Defense (PC170934P2), the University of Chicago Medicine Comprehensive Cancer Center (NIH CCSG: P30 CA014599), and the Ludwig Institute for Metastasis Research.

The additional authors of the study are Kaiyuan Ni, Guangxu Lan, Nining Guo, August Culbert, Taokun Luo, and Tong Wu of the University of Chicago.

Ni, K., et al. (2020) Nanoscale metal-organic frameworks for x-ray activated in situ cancer vaccination. Science Advances. doi.org/10.1126/sciadv.abb5223.

Source: https://www.uchicagomedicine.org/

Continue reading here:
Researchers Use Charged Nanoscale MOFs and X-Rays to Kill Cancer Cells - AZoNano

Dataintelo, one of the worlds leading market research firms has rolled out a new report on Nanotechnology in Drug Delivery market. The report is integrated with crucial insights on the market which will support the clients to make the right business decisions. This research will help both existing and new aspirants for Global Nanotechnology in Drug Delivery Market to figure out and study market needs, market size, and competition. The report provides information about the supply and demand situation, the competitive scenario, and the challenges for market growth, market opportunities, and the threats faced by key players.

The report also includes the impact of the ongoing global crisis i.e. COVID-19 on the Nanotechnology in Drug Delivery market and what the future holds for it. The pandemic of Coronavirus (COVID-19) has landed a major blow to every aspect of life globally. This has lead to various changes in market conditions. The swiftly transforming market scenario and initial and future assessment of the impact are covered in the report.

Request a sample Report of Nanotechnology in Drug Delivery Market: https://dataintelo.com/request-sample/?reportId=101591

The report is fabricated by tracking the market performance since 2015 and is one of the most detailed reports. It also covers data varying according to region and country. The insights in the report are easy to understand and include pictorial representations. These insights are also applicable in real-time scenarios. Components such as market drivers, restraints, challenges, and opportunities for Nanotechnology in Drug Delivery are explained in detail. Since the research team is tracking the data for the market from 2015, therefore any additional data requirement can be easily fulfilled.

The scope of the report has a wide spectrum extending from market scenarios to comparative pricing between major players, cost, and profit of the specified market regions. The numerical data is supported by statistical tools such as SWOT analysis, BCG matrix, SCOT analysis, and PESTLE analysis. The statistics are depicted in a graphical format for a clear picture of facts and figures.

The generated report is strongly based on primary research, interviews with top executives, news sources, and information insiders. Secondary research techniques are utilized for better understanding and clarity for data analysis.

The Nanotechnology in Drug Delivery Market is divided into the following segments to have a better understanding:

By Application:

CancerTumorOther

By Type:

Targeted DeliveryDrug Package

By Geographical Regions:

Ask for Discount on Nanotechnology in Drug Delivery Market Report at: https://dataintelo.com/ask-for-discount/?reportId=101591

The Nanotechnology in Drug Delivery Market industry Analysis and Forecast 20192026 help clients with customized and syndicated reports holding key importance for professionals requiring data and market analytics. The report also calls for market-driven results providing feasibility studies for client requirements. Dataintelo promises qualified and verifiable aspects of market data operating in the real-time scenario. The analytical studies are carried out ensuring client requirements with a thorough understanding of market capacities in the real-time scenario.

Some of the prominent companies that are covered in this report:

Key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report. Following is the list of key players:

Access PharmaceuticalsAlkermesAquanovaCamurusCapsulution PharmaCelgene

*Note: Additional companies can be included on request

Reasons you should buy this report:

Dataintelo provides attractive discounts that fit your needs. Customization of the reports as per your requirement is also offered. Get in touch with our sales team, who will guarantee you a report that suits your needs.

Customized Report and Inquiry for the Nanotechnology in Drug Delivery Market Report: https://dataintelo.com/enquiry-before-buying/?reportId=101591

About US:

DATAINTELO has set its benchmark in the market research industry by providing syndicated and customized research report to the clients. The database of the company is updated on a daily basis to prompt the clients with the latest trends and in-depth analysis of the industry.

Our pool of database contains various industry verticals that include: IT & Telecom, Food Beverage, Automotive, Healthcare, Chemicals and Energy, Consumer foods, Food and beverages, and many more. Each and every report goes through the proper research methodology, validated from the professionals and analysts to ensure the eminent quality reports.

Contact US:

Name: Alex MathewsPhone No.: +1 909 545 6473Email: [emailprotected] Website: https://dataintelo.com Address: 500 East E Street, Ontario, CA 91764, United States.

More here:
Nanotechnology in Drug Delivery Market 2020 To Witness High Growth In Near Future | Top Key Players Like Access Pharmaceuticals, Alkermes, Aquanova,...

A World's First That Combines Innovative Technologies: Titan nanoLOCK Surface Technology and Navigation

DUBLIN, Oct. 7, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the U.S. launch of Adaptix Interbody System, the first navigated titanium implant with Titan nanoLOCK Surface Technology, a proprietary blend of surface textures on the macro, micro, and nano levels. The Adaptix Interbody System, mirrored after the veteran Capstone Spinal System, touts improved features for increased strength,1 subsidence resistance,1,2,3 easy insertion, and data-backed bone growth4,5. The announcement was made during the virtual edition of the North American Spine Society (NASS) annual meeting. Adaptix received U.S. Food and Drug Administration (FDA) approval in August 2020.

This milestone represents the first 3D printed titanium implant, developed in house by Medtronic engineers, that incorporates the state-of-the-art Titan nanoLOCK Surface Technology.

Titan Spine, acquired in 2019, pioneered this surface technology that is the first to demonstrate the elements to be considered a nanotechnology for spinal devices as outlined in the FDA nanotechnology guidance document. Interbody implants are spacers that surgeons may insert between the vertebrae during spinal fusion surgery to help relieve pressure on nerves and hold the vertebrae in place while fusion occurs.

"Adaptix Interbody System allows me the best chance to meet my patients' needs by confidently placing the implant under navigation and trusting the Titan nanoLOCK Surface Technology to allow the implant to promote fusion. Surface technology, material type, and implant design all play a role in bone growth process during fusion," said J. Justin Seale, M.D. of OrthoArkansas Spine Institute. "The unique features and world-class technologies make the Adaptix Interbody System a truly differentiated implant."

The Adaptix Interbody System addresses surgeons' universal needs of fusion outcomes and offers:

Medtronic continues to transform spine care and deliver on its Surgical Synergy strategy by offering solutions that integrate implants, biologics, and enabling technologies. Adaptix Interbody System is compatible with the Medtronic navigation platform (StealthStation Navigation and O-arm imaging) and the newly released Grafton DBF Inject, a unique graft delivery syringe that delivers an osteoinductive6 DBM into the surgical site.

"Adaptix Interbody System is an exciting addition to our portfolio that leads with our Titan nanoLOCK Surface Technology," said Sharrolyn Josse, vice president and general manager of Medtronic Core Spine and Biologics division, which is part of the Restorative Therapies Group at Medtronic. "It is a fully navigated procedure, leveraging our leadership in navigation."

About MedtronicMedtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

1 Comparison of Adaptix and Capstone testing per ASTM F2077and ASTM F2267.2 Based on surface area measurement.3 Based on engineering principles.4 Wennerberg, A., & Albrektsson, T. (2009). Effects of titanium surface topography on bone integration: a systematic review. Clin Oral Implants Res, 20 Suppl 4, 172-184.5 Gittens, R.A., Olivares-Navarrete, R., Schwartz, Z, Boyan, B.D. (2014). Implant osseointegration and the role of microroughness and nanostructures: lessons for spine implants. Acta Biomater., 10(8), 3363-71.6 Data on file. Animal data is not necessarily indicative of human clinical outcomes.

Contacts:

Victor Rocha

Ryan Weispfenning

Public Relations

Investor Relations

+1-901-399-2401

+1-763-505-4626

View original content to download multimedia:http://www.prnewswire.com/news-releases/medtronic-announces-adaptix-interbody-system-the-first-navigated-titanium-cage-with-titan-nanolock-surface-technology-301147250.html

SOURCE Medtronic plc

Company Codes: NYSE:MDT

Read the original here:
Medtronic Announces Adaptix Interbody System, the First Navigated Titanium Cage with Titan nanoLOCK Surface Technology - BioSpace

Global Covid-19 Impact on Healthcare Nanotechnology market study presents an in-depth scenario Which is segmented according to manufacturers, product type, applications, and areas. This segmentation will provide deep-dive analysis of the Covid-19 Impact on Healthcare Nanotechnology industry for identifying the growth opportunities, development trends and factors limiting the growth of the market. This report offers forecast market information based on previous and current Covid-19 Impact on Healthcare Nanotechnology industry scenarios and growth facets.

The latest report on the Healthcare Nanotechnology market entails latest industry data and projections backed by historical statistics and growth opportunities over the study period. In addition, the report comments on the impact of COVID-19 pandemic on this business sphere.

The report studies in complete details the multiple segmentations, inclusive of the product terrain, application spectrum, and regional territories. Key trends that will influence growth of each segment in the forthcoming years are factored in the report to impart a deeper understanding. Apart from this, a pool of leading players is assessed in the study to decipher the competitive dynamics of this industry vertical.

Request Sample Copy of this Report @ https://www.aeresearch.net/request-sample/306660

Main highlights from the Healthcare Nanotechnology market report:

Geographical landscape of the Healthcare Nanotechnology market:

Healthcare Nanotechnology market segmentation: Americas, APAC, Europe, Middle East & Africa.

A gist of the regional analysis:

Product types and application spectrum of the Healthcare Nanotechnology market:

Product landscape:

Types: Nanomedicine, Nano Medical Devices, Nano Diagnosis, Others, Nanomedicine has the highest percentage of revenue by type and with more than 86% in 2019

Main highlights listed in the report:

Application spectrum:

Application scope: Anticancer, CNS Product, Anti-infective, Others, According to the application and anticancer and CNS products accounted for 17.56% and 22.70% of the market in 2019 respectively

Specifics mentioned in the document:

Competitive outlook of the Healthcare Nanotechnology market:

Companies profiled in the study: Amgen, Stryker, Teva Pharmaceuticals, UCB, Roche, Abbott, Merck & Co, Celgene, Biogen, Sanofi, Leadiant Biosciences, Shire, Kyowa Hakko Kirin, Gilead Sciences, Johnson & Johnson, 3M Company, Endo International, Smith & Nephew, Pfizer and Ipsen

Key pointers from the report:

The Healthcare Nanotechnology Market Report Addresses the Following Queries:

Request Customization on This Report @ https://www.aeresearch.net/request-for-customization/306660

See original here:
Healthcare Nanotechnology Market: Opportunities, Demand and Forecasts, 2020 - News by aeresearch

Researchers at Tel Aviv University have designed a drug delivery system for the treatment of skin cancer melanoma that relies on nanotechnology, according to a university statement.The "nanocarrier" is made up of biocompatible and biodegradable polymer, which is comprised of "repeating units of glutamic acids" (PGA - polyglutamic acid), and packages two different families of drugs together that have both been proven to be effective in the treatment of melanoma: BRAF inhibitors (Dabrafenib) and MEK inhibitors (Selumetinib)."One of the major obstacles of the biological treatments is that after a while, the cancer cells develop resistance to the drugs," said leading researcher Prof. Ronit Satchi-Fainaro from the Department of Physiology and Pharmacology at the Sackler School of Medicine. "We assume that by precise delivery of two or more targeted drugs that will attack the cancer cells forcefully and simultaneously from different directions, we can delay or even prevent the acquisition of this drug-resistance."Their findings were published in the August 2020 issue of Advanced Therapeutics as the cover article."In this project, we looked for a solution to a problem often associated with drug cocktails," Satchi-Fainaro said."Today, most oncological treatments are administered in the form of cocktails of several medications. However, despite the fact that all drugs are administered to the patient simultaneously, they do not reach the tumor at the same time, due to differences in basic parameters like how long they survive in the bloodstream (i.e. half-life), and the time it takes each drug to reach the tumor tissue. Thus, in most cases, the medications do not work concurrently, which prevents them from attaining optimal synergistic activity."In order to address these issues, the researchers teamed the two families of drugs together with the intention of introducing them to the tumor via a nanocarrier which itself is biodegradable, and made up of amino acids.The researchers tested the medications against the levels and forms of toxicity they produced, as well as the tolerance of cancer cells with regard to the treatment in order to "ensure maximum effectiveness, minimal toxicity and optimal synergistic activity." Considering the introduction method, being a mix of two different drugs, lower dosages of the cancer treatment medications are needed than when using each independently. cnxps.cmd.push(function () { cnxps({ playerId: '36af7c51-0caf-4741-9824-2c941fc6c17b' }).render('4c4d856e0e6f4e3d808bbc1715e132f6'); });"The next step was using chemical modifications to enable bonding between the polymeric carrier and the chosen drugs. This combined system can travel through the body with total safety, inflicting no damage to healthy tissues," Tel Aviv University explained in a statement. "Upon reaching the cancer cells, the nanocarrier encounters proteins of the cathepsins enzyme family, which are highly activated in malignant tumors. The proteins degrade the polymer, releasing the drugs which become active and join forces to attack the tumor.""It's like several passengers riding in one cab and getting off together at the same address. They all arrive at the same destination, right at the same time," said Satchi-Fainaro.The researchers have tested the method on mice, which showed promising results, the university noted. Within the animal study, the researchers found that the drug could be administered in lower doses, and that the treatment in itself is much safer and effective than independent treatments using a different administration method."In this project, we developed an innovative drug delivery system for treating melanoma, delivering two proven medications and releasing them simultaneously at the tumor site. The treatment proved both safer and more effective than the same medications administered as a cocktail. Moreover, our new platform is highly modular and can be used for delivering a vast range of medications. We believe that its potential for enhancing therapeutics for different diseases is practically endless," concluded Satchi-Fainaro.

Visit link:
Tel Aviv University attempts to treat skin cancer with nanotechnology - The Jerusalem Post

Scanning Acoustic Microscopy (SAM) Markethas been riding a progressive growth trail over the recent past. The first two quarters of the year 2020 have however witnessed heavy disruptions throughout all the industry facets, which are ultimately posing an unprecedented impact onScanning Acoustic Microscopy (SAM) market. Although healthcare & life sciences industry as a whole is witnessing an influx of opportunities in selected sectors, it remains a matter of fact that some of the industry sectors have temporarily scaled back. It becomes imperative to stay abreast of all the recent updates and predict the near future wisely.

The report primarily attempts to track the evolution of growth path of market from 2019, through 2020, and post the crisis. It also provides long-term market growth projections for a predefined period of assessment, 2020 2025. Based on detailed analysis of industrys key dynamics and segmental performance, the report offers an extensive assessment of demand, supply, and manufacturing scenario. Upsurge in R&D investments, increasing sophistication of healthcare infrastructure, thriving medical tourism, and rapidly introducing innovations in Scanning Acoustic Microscopy (SAM) and equipment sector are thoroughly evaluated.

NOTE: Our team is studying Covid-19 impact analysis on various industry verticals and Country Level impact for a better analysis of markets and industries. The 2020 latest edition of this report is entitled to provide additional commentary on latest scenario, economic slowdown and COVID-19 impact on overall industry.

Request Free Sample Report Scanning Acoustic Microscopy (SAM) industry outlook @ Key players in the global Scanning Acoustic Microscopy (SAM) market covered in Chapter 4: OKOS Solutions, Kraemer Sonic Industries, PVA TePla Analytical Systems, Toho Technology, Sonix, Inc., The Crest Group, Insidix, Astronics, Ceramatec, Inc

In Chapter 11 and 13.3, on the basis of types, the Scanning Acoustic Microscopy (SAM) market from 2020 to 2025 is primarily split into:MicroscopesAccessories & SoftwareServices

In Chapter 12 and 13.4, on the basis of applications, the Scanning Acoustic Microscopy (SAM) market from 2020 to 2025 covers:SemiconductorLife ScienceMaterial ScienceNanotechnologyOthers

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:

United States, Canada, Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium, China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia, Brazil, Mexico, Argentina, Columbia, Chile, Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of the World

Some Points from Table of Content

Global Scanning Acoustic Microscopy (SAM) Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026

Chapter 1Report Overview

Chapter 2Global Market Growth Trends

Chapter 3Value Chain of Scanning Acoustic Microscopy (SAM) Market

Chapter 4Players Profiles

Chapter 5Global Scanning Acoustic Microscopy (SAM) Market Analysis by Regions

Chapter 6North America Scanning Acoustic Microscopy (SAM) Market Analysis by Countries

Chapter 7Europe Scanning Acoustic Microscopy (SAM) Market Analysis by Countries

Chapter 8Asia-Pacific Scanning Acoustic Microscopy (SAM) Market Analysis by Countries

Chapter 9Middle East and Africa Scanning Acoustic Microscopy (SAM) Market Analysis by Countries

Chapter 10South America Scanning Acoustic Microscopy (SAM) Market Analysis by Countries

Chapter 11Global Scanning Acoustic Microscopy (SAM) Market Segment by Types

Chapter 12Global Scanning Acoustic Microscopy (SAM) Market Segment by Applications

Chapter 13Scanning Acoustic Microscopy (SAM) Market Forecast by Regions (2020-2026)

Chapter 14Appendix

Impact of Covid-19 in Scanning Acoustic Microscopy (SAM) Market: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Scanning Acoustic Microscopy (SAM) market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

Points Covered in the Report

>>>>Get Full Customize report @ https://www.reporthive.com/request_customization/2330965

Get in Touch with Us :Report Hive Research500, North Michigan Avenue,Suite 6014,Chicago, IL 60611,United StatesWebsite: : https://www.reporthive.comEmail: [emailprotected]

See the original post:
Scanning Acoustic Microscopy (SAM) Market Analysis Report, Region, Application, Trends, Competitive Market Share and Forecast to 2025 | OKOS...